For Two Decades, One Volume Has Offered Complete Coverage of The IVD Industry
Now with a March 2023 Addendum
The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.
This report was PUBLISHED in August 2022. Years covered in forecast are 2022-2027
BUY NOW AND GET A SPECIAL 2023 Market Addendum with 20 Test Categories in 2023 Market Forecasts, Recent Trends and Company Info
The report has complete IVD market research sections with test segment estimates and forecasts in: Clinical Chemistry, Hematology, Histology, Company Profiles and Rankings, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, Point of Care. This is every significant segment in in vitro diagnostics.
Every significant test category in IVD is given a chapter with sub-segments. It’s like having ten market research reports in one.
Published since 1999, this 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. Kalorama’s full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostics Tests the most trusted report by top companies in the industry.
This report is published in August 2022 but analysts have created a special section to describe and project market changes in 2023.
WHAT’S WITHIN THE SEGMENT? Detail on Important Test Markets
The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature. All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer’s product innovations. This detailed look at the IVD market yields unparalleled global market modeling.
Why The Worldwide Market for In Vitro Diagnostic Tests?
- Maximum Value: One Report, All Segments, World Markets
- Published Since 1999, by an Expert Firm That Focuses on IVD and Related Healthcare
- Profiles of 300+ Companies in the Market, Detail on the Top 40
- Use the Industry-Utilized and Business Planning Numbers
- Learn Who is Launching Products and Investing in the IVD Industry
- Overall IVD Markets for Every Significant Nation, Detail for Major Markets
- Based on Latest Financial Reporting, Real-World Industry and Medical Practice Trends
This report gives you definitive answers to important questions like:
- What is the Size of IVD Market Segments?
- Within Those Segments, How Do They Break Down?
- Where Will Those Markets be In Five Years?
- How Has the IVD Market Changed Over Time?
- Who’s Winning?
- Who’s Merged?
- Who’s Launched Game-Changing Products?
- What is the Competitive Landscape?
- Who Can I Partner With?
- Where are the Growth Markets I Can Enter or Buy Into?
- And more…
The most essential report on the IVD industry, The Worldwide Market for In Vitro Diagnostic Test, is a must-have tool for understanding the IVD market on a deeper level. Interested in learning more? Contact us today!
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 14th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally.
Overall IVD market size for every significant world country. Detail for major market segments, US, Japan, Europe, China.
Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
- South Korea
- Saudi Arabia
- South Africa
- Eastern Europe
- Emerging Markets
- Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2022.
Competitive Analysis and Corporate Profiling
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.
Profiles of IVD-relevant companies. No other resource comes close.
First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.
Companies profiled include these, and many others:
Accelerate Diagnostics, Inc.
Amoy Diagnostics Co. Ltd.
Ascensia Diabetes Care Holdings AG
Becton Dickinson (BD)
BGI Genomics (formerly Beijing Genome Institute)
Binding Site Group Ltd. (The)
Cepheid / Danaher
Corgenix Medical Corporation
Cynvenio Biosystems (LungLife AI)
Diagnostica Stago, S.A.S.
DIAGON Kft. Hungary
Edico Genome (Illumina)
Eiken Chemical Co., Ltd
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
ERBA Diagnostics, Inc.
Fujirebio Diagnostics, Inc.
Genomic Health (Exact Sciences)
Greiner Bio-One International GmbH
Guardant Health, Inc.
Hain Lifescience GmbH
HTG Molecular Diagnostics
Human Longevity Inc.
Immunodiagnostic Systems (IDS)
INOVA Diagnostics, Inc.
Meridian Bioscience, Inc.
PerkinElmer, Inc. (PE)
Randox Laboratories Ltd.
Rennova Health, Inc.
Response Biomedical Corp.
Sekisui Diagnostics LLC
Shimadzu Scientific Instruments
Snibe Co. Ltd.
Thermo Fisher Scientific
Trinity Biotech Plc